Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Vitale

Showing results (41-50 of 530) with videos related to

Pageof 53
Sort By:
Minerva Ginecologica|June 1, 1994
[Anomalous uterine bleeding in the perimenopause: fibromatosis, hyperplastic endometriopathy and GnRH analogs]G Vitale, M Linciano, S Salamanca, et al.
Clinical Orthopaedics and Related Research|August 2, 2002
Orthopaedic manifestations of neurofibromatosis in children: an updateMichael G Vitale, Abhijit Guha, David L Skaggs
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2021
Checkpoint inhibitor therapy for skin cancer may be safe in patients with asymptomatic COVID-19C Trojaniello, M G Vitale, P A Ascierto
Acta Crystallographica. Section D, Biological Crystallography|October 29, 2000
Expression, crystallization and preliminary X-ray diffraction studies of recombinant Bacillus anthracis lethal factorL Bernardi, G Vitale, C Montecucco, et al.
Farmaco (Societa Chimica Italiana : 1989)|March 19, 1999
Quinoxaline chemistry. Part 12. 3-Carboxy-2[phenoxy]-6(7)substituted quinoxalines and N-[4-(6(7) substituted-3-carboxyquinoxalin-2-yl)hydroxy] benzoylglutamates. Synthesis and evaluation of in vitro anticancer activityG Vitale, P Corona, M Loriga, et al.
Cell|November 3, 1995
Rabaptin-5 is a direct effector of the small GTPase Rab5 in endocytic membrane fusionH Stenmark, G Vitale, O Ullrich, et al.
Minerva Endocrinologica|July 30, 2004
Cardiovascular complications in acromegalyG Vitale, R Pivonello, G Lombardi, et al.
Farmaco (Societa Chimica Italiana : 1989)|April 27, 2000
Quinoxaline chemistry. Part 13: 3-Carboxy-2-benzylamino-substituted quinoxalines and N-[4-[(3-carboxyquinoxalin-2-yl) aminomethyl]benzoyl]-L-glutamates: synthesis and evaluation of in vitro anticancer activityP Corona, G Vitale, M Loriga, et al.
Farmaco (Societa Chimica Italiana : 1989)|May 30, 1998
Quinoxaline chemistry. Part 10. Quinoxaline 10-oxa-analogues of trimetrexate (TMQ) and of 5,8-dideazafolic acid. Synthesis and evaluation of in vitro anticancer activityG Vitale, P Corona, M Loriga, et al.
Minerva Anestesiologica|December 1, 1991
[Treatment of decompression sickness in Toscana]L Ferri, M Balatresi, G Vitale, et al.
Pageof 53

Showing results (41-50 of 530) with videos related to

Sort By:
Pageof 53
Minerva Ginecologica|June 1, 1994
[Anomalous uterine bleeding in the perimenopause: fibromatosis, hyperplastic endometriopathy and GnRH analogs]G Vitale, M Linciano, S Salamanca, et al.
Clinical Orthopaedics and Related Research|August 2, 2002
Orthopaedic manifestations of neurofibromatosis in children: an updateMichael G Vitale, Abhijit Guha, David L Skaggs
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2021
Checkpoint inhibitor therapy for skin cancer may be safe in patients with asymptomatic COVID-19C Trojaniello, M G Vitale, P A Ascierto
Acta Crystallographica. Section D, Biological Crystallography|October 29, 2000
Expression, crystallization and preliminary X-ray diffraction studies of recombinant Bacillus anthracis lethal factorL Bernardi, G Vitale, C Montecucco, et al.
Farmaco (Societa Chimica Italiana : 1989)|March 19, 1999
Quinoxaline chemistry. Part 12. 3-Carboxy-2[phenoxy]-6(7)substituted quinoxalines and N-[4-(6(7) substituted-3-carboxyquinoxalin-2-yl)hydroxy] benzoylglutamates. Synthesis and evaluation of in vitro anticancer activityG Vitale, P Corona, M Loriga, et al.
Cell|November 3, 1995
Rabaptin-5 is a direct effector of the small GTPase Rab5 in endocytic membrane fusionH Stenmark, G Vitale, O Ullrich, et al.
Minerva Endocrinologica|July 30, 2004
Cardiovascular complications in acromegalyG Vitale, R Pivonello, G Lombardi, et al.
Farmaco (Societa Chimica Italiana : 1989)|April 27, 2000
Quinoxaline chemistry. Part 13: 3-Carboxy-2-benzylamino-substituted quinoxalines and N-[4-[(3-carboxyquinoxalin-2-yl) aminomethyl]benzoyl]-L-glutamates: synthesis and evaluation of in vitro anticancer activityP Corona, G Vitale, M Loriga, et al.
Farmaco (Societa Chimica Italiana : 1989)|May 30, 1998
Quinoxaline chemistry. Part 10. Quinoxaline 10-oxa-analogues of trimetrexate (TMQ) and of 5,8-dideazafolic acid. Synthesis and evaluation of in vitro anticancer activityG Vitale, P Corona, M Loriga, et al.
Minerva Anestesiologica|December 1, 1991
[Treatment of decompression sickness in Toscana]L Ferri, M Balatresi, G Vitale, et al.
Pageof 53